ADAPTIMMUNE THERAPEUTICS PLC Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of GBP 0.63 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2019-02-27
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2018 was 0.63 GBP.
GBP
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2018-12-31 | 0.63 GBP 10-K · filed 2019-02-27 |
USD/shares
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2017-12-31 | $0.62 10-K · filed 2018-03-15 |
| 2016-12-31 | $0.89 10-K · filed 2017-03-13 |
| 2015-06-30 | $0.84 8-K · filed 2016-07-08 |
GBP/shares
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2018-12-31 | 0.63 GBP/shares 10-K · filed 2019-02-27 |